Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled “Low Glycemic Sugar Composition.” cover

Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition." cover

Trending Tickers

[content_inside_smallcaps_data1]
[mc4wp_form id=68192]
Back to top button